Tranexamic Acid (TXA) treatment

DRUG3 trials

Sponsors

HaEmek Medical Center, Israel, King Abdullah International Medical Research Center, Louisiana State University Health Sciences Center in New Orleans

Conditions

AnemiaAngioectasiasBlood LossEpinephrineFemur SurgeryKnee Arthritis, OsteoarthritisKnee Arthroplasty, TotalSmall Bowel Bleeding

Phase 2

Tranexamic Acid for The Management of Bleeding Gastrointestinal Angioectasias

CompletedNCT07125508

Louisiana State University Health Sciences Center in New OrleansAnemia, Angioectasias, Small Bowel Bleeding

Start: 2023-08-01End: 2024-12-15Updated: 2025-08-15

Phase 4

The Use of Tranexamic Acid (TXA) Intravenously, to Reduce Blood Loss in Proximal Femur Surgery

WithdrawnNCT02164565

HaEmek Medical Center, IsraelFemur Surgery

Start: 2014-06-30End: 2015-03-31Updated: 2017-08-16

The Perioperative Outcome of Epinephrine Infusion and Tranexamic Acid in Knee Arthroplasty Surgery

RecruitingNCT07089251

King Abdullah International Medical Research CenterBlood Loss, Epinephrine, Knee Arthritis, Osteoarthritis +3

Start: 2025-07-15End: 2027-06-24Target: 80Updated: 2025-07-28